Found 41 matching trials
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC
PHASE1The purpose of this trial is to learn more about the effects of AAA602 and ...
Location
Multiple Locations
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
PHASE2This prospective phase II study assesses the accuracy of second generation ...
Location
University of Alberta
Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
N/AFollowing numerous retrospective studies and Phase-3-Studies with promising...
Location
Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
PHASE3This study evaluates the diagnostic performance and safety of F-18-PSMA-100...
Location
Centre Jean Perrin Clermont-Ferrand
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NAThe goal of this clinical study is to test the performance of PSMA PET/MRI-...
Location
Aarhus University Hospital
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
NAThis study is a multi-center RCT to compare the clinically significant pros...
Location
Prince of Wales Hospital
Diagnostic Accuracy and Performance of 18F-PSMA-1007
N/AWhereas 18F-PSMA-1007 has rapidly established itself as a radiotracer for t...
Location
Inselspital, Universitätsspital Bern
Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer
NARationale: In patients with medullary thyroid cancer (MTC), molecular imagi...
Location
University Medical Centre Groningen
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NAIn 22% of patients with elevated Prostate-specific antigen (PSA) MRI guided...
Location
University Hospital Zurich
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
PHASE2Single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT ima...
Location
University of Alberta